Cordis Says Medtronic Stent Patents Unenforceable
Cordis Corp. fired back on Tuesday to a suit in which Medtronic Inc. accused it of infringing two patents for coronary stents, arguing that the two patents at issue are unenforceable...To view the full article, register now.
Already a subscriber? Click here to view full article